不聪明怎么办

Williams DM, Heikkinen S, Hiltunen M, et al.  (2026). The proportion of Alzheimer's disease attributable to apolipoprotein E. NPJDementia 2:1. 

1. NamY, DeRosaBA, RamirezAM,et al.(2025).Disrupted Lipid Homeostasis as a Pathogenic Mechanism inABCA7-Associated Alzheimer’s Disease Risk.bioRxiv 2025.09.03.673792.

2. Hu M, Knopman DS, Therneau T, et al.(2026). Breakpoints in Alzheimer's disease biomarkers and cognition across the aging spectrum: The Mayo Clinic Study of Aging. Alzheimer's &Dementia22:e71227.

3. Borelli PV, Machado L, Carello-Collar G, et al.(2026). Diagnostic performance of salivary markers of Alzheimer's disease: A systematic review. Alzheimer's &Dementia 22:e71248.

4. Yang NV, Wang S, Li B, et al. (2026).TOMM40suppression promotes neuronal cholesterol imbalance and molecular and behavioral phenotypes of Alzheimer's disease.Alzheimer's &Dementia 22:e71306.

5. Cavaillès C, Carnethon MR, Knutson KL, Thomas SJ, Yaffe K.(2026). Midlife sleep characteristics and Alzheimer's disease biomarkers 20 years later.Alzheimer's &Dementia 22:e71342.

6. Yang J, Wang J, Chai W, et al.(2026). Elevated plasma klotho levels attenuate Alzheimer's disease pathologies and cognitive decline inAPOE ε4 carriers.Alzheimer's &Dementia22:e71397.

7. van Etten ES, Mahinrad S, Grill JD, et al.(2026). Amyloid-related imaging abnormalities (ARIA) in anti-amyloid therapies for Alzheimer's disease: An update from the Alzheimer's Association ARIA workgroup.Alzheimer's &Dementia 22:e71361.

8. Farrell C, Saini F, Beidas MM, Ryan NS, Strydom A, Wiseman FK.(2026). Use of anti-amyloid-β monoclonal antibodies in persons with Down syndrome Alzheimer's disease.Alzheimer's &Dementia22:e71404.

9. Ray NR, Kurup J, Kumar A, et al.(2026). Genetic correlation analysis of Alzheimer's disease and stroke implicatesPHLPP1 as a shared locus in individuals of African ancestry.Alzheimer's &Dementia 22:e71433.

10. Godale CM, Yaser S, Drake AW, et al.(2026). Cell-Intrinsic Regulation of Epilepsy-Associated Pathology by mTORC1 and mTORC2.The Journal ofNeuroscience 46:e1211252026.

11. Kawano N, Kikuchi I.(2026). Membranoproliferative Glomerulonephritis Due to Cryoglobulinemia.The New EnglandJournal ofMedicine 394:1736.

12. VinanicaN, YeoJ, Hamran NA, CampanaD.(2026).A CHIMERIC RECEPTOR ENABLING ANTIBODY-GUIDED RETARGETING OF CAR T- CELLS.bioRxiv2026.04.27.720976.

13. BayraktarG, DannersøJK, HansenSD,et al.(2026).Double Periodicity of the AnkyrinG-Associated Complex in the Axon Initial Segment.bioRxiv2026.04.25.720723.

14. S Kumar, A Haber, C Spruce,et al.(2026).PSEN1 mutant marmoset fibroblasts mimic multi-omic signatures of Alzheimer’s disease.bioRxiv 2026.04.24.720222.

15. BahmaniL, GalvanP, HosseiniH, et al.(2026).mGluR6 coordinates cone terminal targeting and synaptic layer assembly during human retinal development.bioRxiv 2026.04.23.720451.

Martin-Higueras C, Torres A, Salido E. (2017). Molecular therapy of primary hyperoxaluria.Journal ofInheritedMetabolicDisease 40:481–489.

Rubin JD, Barry MA. (2020). Improving Molecular Therapy in the Kidney. MolecularDiagnosis &Therapy 24:375–396. 

Mullard A. (2026). Dual-vector gene therapy for hearing loss secures first FDA approval. NatureReviews. DrugDiscovery, 10.1038/d41573-026-00075-9. Advance online publication.

Liew PX, Kubes P.(2019). The Neutrophil's Role During Health and Disease.PhysiologicalReviews 99:1223–1248.

Kolaczkowska E, Kubes P.(2013). Neutrophil recruitment and function in health and inflammation. NatureReviews Immunology 13:159–175.